gnb 바로가기 본문 바로가기
Challenge Bio Further Bio
vision & agenda
With COVID-19 and next steps for K-BIO

Back to normal

We will diagnos how ‘With COVID-19’ policy could change our daily life in the future, and what measures to take in the midst of the COVID-19 pandemic.

Conquering the cancer

Introduction of anti-cancer drug development technologies that took a leap forward, such as CAR-T, which opened the way to cure blood cancer, and novel anticancer drug pipelines using the COVID-19 vaccine platform.

K-Bio's survival strategy

We will look into actual ‘M&A’ cases considered to be K-Bio's strategy to enter the global market, and point out key implications.